Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 25, 2021

SELL
$48.52 - $58.02 $10.3 Million - $12.3 Million
-212,320 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$53.07 - $61.1 $864,669 - $995,502
-16,293 Reduced 7.13%
212,320 $11.6 Million
Q2 2020

Jul 23, 2020

SELL
$43.1 - $55.31 $6.83 Million - $8.77 Million
-158,482 Reduced 40.94%
228,613 $12.1 Million
Q1 2020

Apr 30, 2020

SELL
$37.79 - $51.33 $2.03 Million - $2.76 Million
-53,695 Reduced 12.18%
387,095 $17.3 Million
Q4 2019

Jan 21, 2020

SELL
$42.46 - $50.46 $4.71 Million - $5.6 Million
-111,008 Reduced 20.12%
440,790 $22 Million
Q3 2019

Oct 28, 2019

SELL
$40.12 - $45.47 $1.1 Million - $1.25 Million
-27,528 Reduced 4.75%
551,798 $24.6 Million
Q2 2019

Jul 29, 2019

SELL
$37.28 - $41.68 $776,728 - $868,402
-20,835 Reduced 3.47%
579,326 $23.9 Million
Q1 2019

Apr 30, 2019

SELL
$35.49 - $43.02 $642,510 - $778,834
-18,104 Reduced 2.93%
600,161 $24.3 Million
Q4 2018

Feb 01, 2019

SELL
$36.86 - $41.49 $430,377 - $484,437
-11,676 Reduced 1.85%
618,265 $23.5 Million
Q3 2018

Jan 04, 2019

BUY
$34.76 - $39.72 $17.7 Million - $20.2 Million
508,579 Added 419.06%
629,941 $24.9 Million
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $18.2 Million - $20.8 Million
-523,959 Reduced 81.19%
121,362 $0
Q2 2018

Jul 24, 2018

SELL
$34.55 - $37.05 $101,576 - $108,926
-2,940 Reduced 0.45%
645,321 $22.7 Million
Q1 2018

Apr 19, 2018

SELL
$32.97 - $36.63 $148,529 - $165,018
-4,505 Reduced 0.69%
648,261 $22.7 Million
Q4 2017

Feb 14, 2018

SELL
$32.09 - $34.78 $14,280 - $15,477
-445 Reduced 0.07%
652,766 $22.7 Million
Q3 2017

Nov 15, 2017

BUY
$28.96 - $34.0 $18.9 Million - $22.2 Million
653,211
653,211 $22.1 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $240B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Janney Capital Management LLC Portfolio

Follow Janney Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Capital Management LLC with notifications on news.